Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125560661 | 12556066 | 1 | I | 20160630 | 20160714 | 20160714 | EXP | US-ACORDA-ACO_125915_2016 | ACORDA | 0.00 | F | Y | 0.00000 | 20160714 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125560661 | 12556066 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | Unknown | 10 MG, Q 12 HRS | 0000079809 | 22250 | 10 | MG | TABLET | Q12H | |||||
| 125560661 | 12556066 | 2 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | 20 MG, UNK | U | 0 | 20 | MG | ||||||||
| 125560661 | 12556066 | 3 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | 40 MG, UNK | U | 0 | 40 | MG | ||||||||
| 125560661 | 12556066 | 4 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | 15 UNK, | U | 0 | ||||||||||
| 125560661 | 12556066 | 5 | C | KLONOPIN | CLONAZEPAM | 1 | 0.5 MG, UNK | U | 0 | .5 | MG | ||||||||
| 125560661 | 12556066 | 6 | C | LORATADINE. | LORATADINE | 1 | 10 MG, UNK | U | 0 | 10 | MG | ||||||||
| 125560661 | 12556066 | 7 | C | QUETIAPINE FUMARATE. | QUETIAPINE FUMARATE | 1 | 300 MG, UNK | U | 0 | 300 | MG | ||||||||
| 125560661 | 12556066 | 8 | C | QUETIAPINE FUMARATE. | QUETIAPINE FUMARATE | 1 | 50 MG, UNK | U | 0 | 50 | MG | ||||||||
| 125560661 | 12556066 | 9 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | 150 MG, UNK | U | 0 | 150 | MG | ||||||||
| 125560661 | 12556066 | 10 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 1000 ?G, UNK | U | 0 | 1000 | UG | ||||||||
| 125560661 | 12556066 | 11 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 5000 IU, UNK | U | 0 | 5000 | IU | ||||||||
| 125560661 | 12556066 | 12 | C | FLUTICASONE | FLUTICASONEFLUTICASONE PROPIONATE | 1 | 50 ?G, UNK | U | 0 | 50 | UG | ||||||||
| 125560661 | 12556066 | 13 | C | METRONIDAZOLE. | METRONIDAZOLE | 1 | 500 MG, UNK | U | 0 | 500 | MG | ||||||||
| 125560661 | 12556066 | 14 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 20 MG, UNK | U | 0 | 20 | MG | ||||||||
| 125560661 | 12556066 | 15 | C | NUEDEXTA | DEXTROMETHORPHAN HYDROBROMIDEQUINIDINE SULFATE | 1 | 20/10 MG, UNK | U | 0 | ||||||||||
| 125560661 | 12556066 | 16 | C | Fish oil | FISH OIL | 1 | 1200 MG, UNK | U | 0 | 1200 | MG | ||||||||
| 125560661 | 12556066 | 17 | C | SENNA PLUS | DOCUSATE SODIUMSENNOSIDESSENNOSIDES A AND B | 1 | 8.6/50 MG, UNK | U | 0 | ||||||||||
| 125560661 | 12556066 | 18 | C | MEMANTINE. | MEMANTINE | 1 | 10 MG, UNK | U | 0 | 10 | MG | ||||||||
| 125560661 | 12556066 | 19 | C | Amitriptyline | AMITRIPTYLINE | 1 | 25 MG, UNK | U | 0 | 25 | MG | ||||||||
| 125560661 | 12556066 | 20 | C | PREDNISONE. | PREDNISONE | 1 | 20 MG, UNK | U | 0 | 20 | MG | ||||||||
| 125560661 | 12556066 | 21 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 50000 IU, UNK | U | 0 | 50000 | IU | ||||||||
| 125560661 | 12556066 | 22 | C | GABAPENTIN. | GABAPENTIN | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125560661 | 12556066 | 1 | Multiple sclerosis |
| 125560661 | 12556066 | 2 | Product used for unknown indication |
| 125560661 | 12556066 | 5 | Product used for unknown indication |
| 125560661 | 12556066 | 6 | Product used for unknown indication |
| 125560661 | 12556066 | 7 | Product used for unknown indication |
| 125560661 | 12556066 | 9 | Product used for unknown indication |
| 125560661 | 12556066 | 10 | Product used for unknown indication |
| 125560661 | 12556066 | 11 | Product used for unknown indication |
| 125560661 | 12556066 | 12 | Product used for unknown indication |
| 125560661 | 12556066 | 13 | Product used for unknown indication |
| 125560661 | 12556066 | 14 | Product used for unknown indication |
| 125560661 | 12556066 | 15 | Product used for unknown indication |
| 125560661 | 12556066 | 16 | Product used for unknown indication |
| 125560661 | 12556066 | 17 | Product used for unknown indication |
| 125560661 | 12556066 | 18 | Product used for unknown indication |
| 125560661 | 12556066 | 19 | Product used for unknown indication |
| 125560661 | 12556066 | 20 | Product used for unknown indication |
| 125560661 | 12556066 | 21 | Product used for unknown indication |
| 125560661 | 12556066 | 22 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125560661 | 12556066 | OT |
| 125560661 | 12556066 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125560661 | 12556066 | Colon operation | |
| 125560661 | 12556066 | Multiple sclerosis relapse |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125560661 | 12556066 | 1 | 20141111 | 0 |